Euroapi S.A.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a EAPIF research report →
About the company
Established in 2021 and headquartered in Paris, France, Euroapi SA specializes in the end-to-end process, from development and manufacturing to marketing and distribution, of active pharmaceutical ingredients (APIs) and various intermediary compounds. These essential materials are then utilized in the formulation of a wide array of medicinal products for both human and veterinary applications.
- CEO
- David Seignolle
- IPO
- 2022
- Employees
- 3,187
- HQ
- Paris, FR
Price Chart
- Market Cap
- $144.31M
- P/E
- -0.62
- P/S
- 0.15
- P/B
- 0.17
- EV/EBITDA
- 0.59
- Div Yield
- 0.00%
- Gross Margin
- 16.80%
- Op Margin
- -4.23%
- Net Margin
- -24.83%
- ROE
- -24.26%
- ROIC
- -3.40%
- Revenue
- $847.88M · -7.76%
- Net Income
- $-211,120,897 · -61.65%
- EPS
- $-2.23 · -61.59%
- Op Income
- $199.93K
- FCF YoY
- 215.32%
- 52W High
- $3.74
- 52W Low
- $1.27
- 50D MA
- $1.54
- 200D MA
- $2.38
- Beta
- 0.98
- Avg Volume
- 64
Get TickerSpark's AI analysis on EAPIF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our EAPIF coverage
Recent articles, reports, and earnings notes.
No research on EAPIF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate EAPIF report →Similar companies
Peers in the same neighborhood.